It started with Princeton and grew exponentially! People ask me all the time — what makes Princeton special and so successful? It started with the R&D that was built during and after World War II: FMC, General Foods, and Morton Thiokol required large campuses for experimentation followed by AT&T, David Sarnoff Research Center, American Cyanamid, the Princeton Plasma Physics Lab, and GE Astrospace, all 100-acre research campuses.

In 2016 the Greater Princeton Area is on scale with Palo Alto Research Center, Stanford University, Boston Bio Sector, and MIT. Princeton is the pharmaceutical research center, drug manufacturing hub, and North American HQ for Novo Nordisk, Bristol-Myers Squibb, Janssen Pharmaceuticals, Integra Life Sciences, Solvay, Taiho, Sandoz, and Otsuka.

The research comes looking for the greatest minds and best laboratories, situated between New York and Philadelphia (rail serviced), supported by an inflow of large pharma capital expanding into an open science platform. Large companies tapping into a vast ecosystem of innovators fueled by increased bio company valuations that have tripled in the last 10 years.

Princeton University’s commitment to the research and development business is expanding to incubate start up technologies that are created by their own research and from other pharmaceutical (oncology/neuroscience,) laser, electrical engineering (implantable and wearable medical devices) companies that will want to collaborate on research and the related economics.

Princeton is the melting pot of the world and the center of some of the most dynamic research and scientific minds in the country. The economy for Princeton is moving into an expansion period fueled by pharmaceutical and other sciences, attracting scientists both nationally and globally, looking to make the next innovation that will change the world.

NAI Fennelly, Gerard J. Fennelly, President. 200 Whitehead Road, Suite 222, Hamilton. 609-520-0061. Fax 609-434-3113. E-mail See ads, pages 51 and 52.

Facebook Comments